Hearing Aid Signal Processing for Alzheimer's Disease
Trial Summary
What is the purpose of this trial?
This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheimer's dementia and its potential precursor, known as amnestic mild cognitive impairment. The investigators hypothesize that adults with Alzheimer's dementia represent an extreme case of restricted cognitive ability, such that very low working memory capacity and overall reduced cognitive capacity will limit benefit from advanced signal processing. Thus, the investigators hypothesize that adults with Alzheimer's dementia will receive greater benefit from acoustically simple, high-fidelity hearing aid processing that minimally alters the acoustic signal.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High level of signal manipulation, Advanced signal processing, Complex signal modification, Low level of signal manipulation, Basic Signal Processing, Minimal Signal Alteration, High-Fidelity Hearing Aid Processing for Alzheimer's Disease?
Research shows that digital hearing aids, which use advanced signal processing, can improve speech perception in noisy environments for people with hearing loss. This suggests that similar signal processing techniques might help Alzheimer's patients with hearing difficulties, potentially aiding in better communication and cognitive engagement.12345
Is hearing aid signal processing safe for humans?
How does the treatment 'Hearing Aid Signal Processing for Alzheimer's Disease' differ from other treatments for Alzheimer's?
Research Team
Pam Souza, PhD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for older adults with Alzheimer's dementia or its precursor, amnestic mild cognitive impairment. Participants must speak English, have normal vision or corrected-to-normal vision, sensorineural hearing loss within specific parameters, and a certain level of cognitive function. They should live at home and be able to consent to the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants will use two different hearing aid signal processing strategies, each for 3-5 weeks
Follow-up
Participants are monitored for changes in speech intelligibility and conversation analysis after treatment
Treatment Details
Interventions
- High level of signal manipulation
- Low level of signal manipulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator